Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAS41004 vs Active Reference in Mild to Moderate Plaque Psoriasis
NCT02180464Phase 2Completed
- Sponsor
- Almirall
- Start
- Jun 2014
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of bexarotene in plaque psoriasis (2 arms), sponsored by Almirall. Primary endpoint: Total Symptom Score at Day 28. Started Jun 2014; status: completed.
02
Drugs
bexarotene
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02180464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02180464.